RxDoctor Payments DataLook up a doctor →

Srihari Naidu, MD

Interventional Cardiology · Mineola, NYNPI 1306948302

Payments from drug & device makers

$577,694in general payments, 2019–2025

Across 262 payments — averaging $2204.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$479K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$51K
  • Chiesi USA, Inc.$33K
  • AstraZeneca$3K
  • ZOLL Circulation Inc$3K
  • Abbott$2K
  • plus $7K from 25 others
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ZOLL Circulation Inc$900

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$577,694 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York

Medicare billing

Part B allowed, 2024
$114,600
Medicare patients
288
Services billed
673

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Mineola

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →